173 related articles for article (PubMed ID: 1646194)
1. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists.
Arriagada R; Le Chevalier T; Quoix E; Ruffie P; de Cremoux H; Douillard JY; Tarayre M; Pignon JP; Laplanche A
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1183-90. PubMed ID: 1646194
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques).
Dautzenberg B; Chastang C; Arriagada R; Le Chevalier T; Belpomme D; Hurdebourcq M; Lebeau B; Fabre C; Charvolin P; Guérin RA
Cancer; 1995 Sep; 76(5):779-86. PubMed ID: 8625180
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma.
Le Chevalier T; Arriagada R; Quoix E; Ruffie P; Martin M; Douillard JY; Tarayre M; Lacombe-Terrier MJ; Laplanche A
Lung Cancer; 1994 Mar; 10 Suppl 1():S239-44. PubMed ID: 8087515
[TBL] [Abstract][Full Text] [Related]
4. [Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma].
Bretel JJ; Arriagada R; Le Chevalier T; Baldeyrou P; Grunenwald D; Le Péchoux C; Pellae-Cosset B; Ruffié P
Cancer Radiother; 1997; 1(2):148-53. PubMed ID: 9273186
[TBL] [Abstract][Full Text] [Related]
5. [Combination of chemotherapy (vindesine, lomustine, cisplatin, cyclophosphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: final results of a phase II clinical trial].
Nasr E; Pellae-Cosset B; Arriagada R; Le Chevalier T; Baldeyrou P; Ruffie P; de Cremoux H; Martin M; Tarayre M
Bull Cancer; 1992; 79(7):681-7. PubMed ID: 1334740
[TBL] [Abstract][Full Text] [Related]
6. [Inoperable lung epidermoid cancer non metastasizing. A phase II trial using radiotherapy and combined chemotherapy].
Le Chevalier T; Arriagada R; Baldeyrou P; Martin M; Ruffié P; Duroux P; Tarayre M; Rouesse J
Bull Cancer; 1985; 72(1):25-9. PubMed ID: 4039206
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer.
Wolf M; Hans K; Becker H; Hässler R; von Bültzingslöwen F; Goerg R; Klaasen HA; Dannhäuser J; Holle R; Pfab R
Semin Oncol; 1994 Jun; 21(3 Suppl 4):42-7. PubMed ID: 8209276
[TBL] [Abstract][Full Text] [Related]
8. A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer. An EORTC Lung Cancer Cooperative Group trial.
Planting A; Helle P; Drings P; Dalesio O; Kirkpatrick A; McVie G; Giaccone G
Ann Oncol; 1996 Feb; 7(2):139-44. PubMed ID: 8777169
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.
Fournel P; Robinet G; Thomas P; Souquet PJ; Léna H; Vergnenégre A; Delhoume JY; Le Treut J; Silvani JA; Dansin E; Bozonnat MC; Daurés JP; Mornex F; Pérol M;
J Clin Oncol; 2005 Sep; 23(25):5910-7. PubMed ID: 16087956
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.
Le Chevalier T; Arriagada R; Quoix E; Ruffie P; Martin M; Tarayre M; Lacombe-Terrier MJ; Douillard JY; Laplanche A
J Natl Cancer Inst; 1991 Mar; 83(6):417-23. PubMed ID: 1847977
[TBL] [Abstract][Full Text] [Related]
11. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial.
Morton RF; Jett JR; McGinnis WL; Earle JD; Therneau TM; Krook JE; Elliott TE; Mailliard JA; Nelimark RA; Maksymiuk AW
Ann Intern Med; 1991 Nov; 115(9):681-6. PubMed ID: 1656827
[TBL] [Abstract][Full Text] [Related]
12. Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung.
Le Chevalier T; Arriagada R; Baldeyrou P; Martin M; Duroux P; Jacquotte A; Sancho-Garnier H; Rouesse J
Cancer Treat Rep; 1985 May; 69(5):469-72. PubMed ID: 4039979
[TBL] [Abstract][Full Text] [Related]
13. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601).
Tsuchiya S; Ohe Y; Sugiura T; Fuwa N; Kitamoto Y; Mori K; Kobayashi H; Nakata K; Sawa T; Hirai K; Etoh T; Saka H; Saito A; Fukuda H; Ishizuka N; Saijo N;
Jpn J Clin Oncol; 2001 Oct; 31(10):488-94. PubMed ID: 11696618
[TBL] [Abstract][Full Text] [Related]
15. Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
Le Péchoux C; Arriagada R; Le Chevalier T; Bretel JJ; Cosset BP; Ruffié P; Baldeyrou P; Grunenwald D
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):519-25. PubMed ID: 8655375
[TBL] [Abstract][Full Text] [Related]
16. [Combined intra-arterial chemotherapy and radiotherapy in inoperable non-small cell bronchial carcinoma].
Rieber A; Brambs HJ; Kauffmann G; Wannenmacher M; Drings P
Strahlenther Onkol; 1991 Jan; 167(1):14-8. PubMed ID: 1846982
[TBL] [Abstract][Full Text] [Related]
17. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
[TBL] [Abstract][Full Text] [Related]
18. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer.
Johnson DH; Einhorn LH; Bartolucci A; Birch R; Omura G; Perez CA; Greco FA
Ann Intern Med; 1990 Jul; 113(1):33-8. PubMed ID: 2161633
[TBL] [Abstract][Full Text] [Related]
19. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
[TBL] [Abstract][Full Text] [Related]
20. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Segawa Y; Kiura K; Takigawa N; Kamei H; Harita S; Hiraki S; Watanabe Y; Sugimoto K; Shibayama T; Yonei T; Ueoka H; Takemoto M; Kanazawa S; Takata I; Nogami N; Hotta K; Hiraki A; Tabata M; Matsuo K; Tanimoto M
J Clin Oncol; 2010 Jul; 28(20):3299-306. PubMed ID: 20530281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
